SMAD3 and glioblastoma: Palmitoylation of Smad3 mediated by the palmitoyltransferase ZDHHC19, however, promotes the activation of the TGF-β signaling pathway. Moreover, its interaction with EP300 enhances the expression of mesenchymal markers in the mesenchymal subtype of GBM.